Bird & Bird advised Health-Tech-VC on EUR 1.3 million investment in RYVER.AI

Contacts

andrea schlote Module
Andrea Schlote

Counsel
Germany

As a Counsel in our Corporate / M&A Team in Munich, I focus on domestic and international venture capital and venture lending transactions for emerging and high-growth companies.

The international law firm Bird & Bird has advised the Spanish health-tech venture capital firm, Nina Capital, on its investment in the Munich-based health-tech startup, RYVER.AI.

Nina Capital led the financing round, other investors include Bayern Kapital (Germany) and FundF (Austria). The capital will primarily be used for technical development, personnel and computing capacity. RYVER.AI develops generative models that enable medical AI providers to generate a wide range of test and training data quickly and cost-effectively. The start-up aims to solve the data shortage for medical AI without jeopardizing patient privacy. The company develops generative AI to create artificial but highly realistic datasets of radiological images.

Nina Capital was advised by the following Bird & Bird lawyers: counsel Andrea Schlote (lead), Partner Stefan Münch, counsel Dr. Christina Lorenz, associate Louisa Graf (all Corporate/M&A, Munich), Partner Martin von Haller Grønbæk (Commercial, Copenhagen) and associate Yvonne Schaafs (IP, Munich).


News & Deals

More News & Deals
Deal Bird & Bird advises Engrate on €2.5 Million Capital Raise

Jun 26 2025

Read More
News Bird & Bird secures multiple wins at the Women in Business Law Awards 2025

Jun 26 2025

Read More
Deal Bird & Bird advises CapMan Plc on majority acquisition of CAERUS Debt Investments AG

Jun 24 2025

Read More
News Bird & Bird wins Five Awards at the LMG Life Sciences Awards EMEA 2025

Jun 18 2025

Read More
Deal Bird & Bird advises Gulermak Renewables Ltd on the acquisition of a 42.4 MW UK solar project

Jun 18 2025

Read More
Deal Bird & Bird advises Hoivatilat Oyj on the purchase of a care facility portfolio

Jun 17 2025

Read More